🔎 Trials Near Me

Home › Chronic-Phase Myeloid Leukemia › Alabama

Chronic-Phase Myeloid Leukemia clinical trials in Alabama

3 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in Alabama.

Cities in Alabama

Study of Olverembatinib (HQP1351) in Patients With CML-CP

  • Ascentage Investigative Site #1044, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

  • University of Alabama at Birmingham, Birmingham
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Jul 20, 2026 · NCT07091019

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

  • University of Alabama Medicine (UAB Medicine), Birmingham
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jan 12, 2026 · NCT06163430

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.